Rome, Italy

Paolo Monaci

USPTO Granted Patents = 6 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 1999-2010

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Paolo Monaci in Cancer Research

Introduction

Paolo Monaci, an esteemed inventor based in Rome, Italy, is known for his substantial contributions to the field of cancer research through his innovative patents. With a total of six patents, Monaci has played a pivotal role in advancing methods and compositions that enhance treatment options for various carcinomas, particularly those associated with human epidermal growth factor receptor 2 (HER2).

Latest Patents

Monaci's recent patents include groundbreaking inventions such as the "Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof." This patent focuses on synthetic polynucleotides that are codon-optimized for expression in human cellular environments. By targeting the hHER2 tumor-associated antigen, the invention aims to bolster immunity against cancers linked to aberrant hHER2 expression. Another noteworthy patent is the "Recombinant modified adenovirus fiber protein," which details modified adenoviruses that enhance the virus's ability to target and transduce cells that are typically resistant to adenoviral infection. These innovations underscore Monaci's commitment to developing vaccines and pharmaceutical compositions for cancer prevention and treatment.

Career Highlights

Throughout his career, Paolo Monaci has been associated with esteemed institutions, including the Instituto di Ricerche di Biologia Molecolare P. Angeletti S.p.a. His work has not only resulted in innovative patents but has also contributed significantly to the scientific community's understanding of cancer therapies and gene therapies.

Collaborations

Monaci's research efforts have been bolstered through collaborations with notable colleagues such as Riccardo Cortese and Franco Felici. Their combined expertise has resulted in remarkable advancements in gene therapy and the development of effective treatment modalities for cancer.

Conclusion

In summary, Paolo Monaci's contributions to cancer research, characterized by innovative patents and fruitful collaborations, have placed him at the forefront of medical advancements. His work promises to enhance therapeutic options and improve outcomes for patients battling cancer, showcasing the profound impact of innovative thinkers in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…